结合
癌症治疗
药物输送
癌症治疗
计算生物学
癌症
肿瘤细胞
体内
纳米技术
计算机科学
化学
癌细胞
癌症免疫疗法
免疫系统
细胞毒性
药品
癌症研究
透视图(图形)
基因传递
药代动力学
免疫疗法
癌症影像学
药物发现
组合化学
过程(计算)
细胞毒性T细胞
输送系统
药物开发
遗传增强
作者
Hongli Sun,Jiangyue Yao,Manshu Song,Stephanie Trend,Kimberley Parkin,Kathleen M. Davern,Tao Wang
标识
DOI:10.1177/15578100261503777
摘要
Nanobody-drug conjugates (NDCs), which incorporate functional payloads (e.g., cytotoxic agents and immune agonists) into nanobodies, have attracted considerable attention in cancer therapy due to their unique ability to target cancer cells with high precision. This review analyzes the functional components of NDCs, including nanobodies, linkers, and payloads, and provides an integrated perspective on their molecular design, mechanisms of action, and clinical applications. The following four aspects are specifically emphasized: (i) the advantages and disadvantages of nanobodies as drug delivery carriers; (ii) current strategies to improve in vivo pharmacokinetic profiles; (iii) the development of multivalent and multispecific NDCs to enhance target engagement and address tumor heterogeneity; and (iv) the transition from conventional stochastic conjugation to highly homogeneous, site-specific conjugation strategies. These features provide a framework for understanding how NDC design can integrate selective delivery with programmable molecular engineering and may facilitate their future development for precision therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI